Treatment for Vulvovaginitis
For uncomplicated vulvovaginal candidiasis (VVC), either topical antifungal agents or a single 150-mg oral dose of fluconazole are recommended as first-line treatments. 1
Treatment Options Based on Type of Vulvovaginitis
Candida Vulvovaginitis (Most Common Type)
Uncomplicated VVC:
Topical antifungal options (no single agent is superior to others) 1:
- Clotrimazole 1% cream 5g intravaginally for 7-14 days 1
- Clotrimazole 100mg vaginal tablet for 7 days 1
- Clotrimazole 100mg vaginal tablet, two tablets for 3 days 1
- Clotrimazole 500mg vaginal tablet, one tablet as single application 1
- Miconazole 2% cream 5g intravaginally for 7 days 1
- Miconazole 200mg vaginal suppository, one suppository for 3 days 1
- Miconazole 100mg vaginal suppository, one suppository for 7 days 1
- Terconazole 0.4% cream 5g intravaginally for 7 days 1
- Terconazole 0.8% cream 5g intravaginally for 3 days 1
- Terconazole 80mg vaginal suppository, one suppository for 3 days 1
- Butoconazole 2% cream 5g intravaginally for 3 days 1
- Tioconazole 6.5% ointment 5g intravaginally in a single application 1
Oral option:
- Fluconazole 150mg oral tablet, single dose 1
Severe Acute VVC:
- Fluconazole 150mg, given every 72 hours for a total of 2-3 doses 1
C. glabrata Vulvovaginitis (resistant to azoles):
- Topical intravaginal boric acid 600mg daily in a gelatin capsule for 14 days 1
- Nystatin intravaginal suppositories 100,000 units daily for 14 days 1
- Topical 17% flucytosine cream alone or with 3% AmB cream daily for 14 days 1
Recurrent VVC:
- 10-14 days of induction therapy with topical agent or oral fluconazole, followed by fluconazole 150mg weekly for 6 months 1
Non-Candida Vulvovaginitis
- For bacterial vulvovaginitis in children: improved anogenital hygiene, sitz/tub baths, and non-irritating soaps 2
- For specific bacterial infections: targeted antimicrobial therapy based on culture results 3
- For parasitic causes (e.g., Enterobius vermicularis): appropriate antiparasitic treatment 4
Special Considerations
For Children
- Vulvovaginitis in prepubertal girls is often non-specific and related to poor hygiene 5, 2
- Topical antibiotics may be preferable to systemic antibiotics to reduce side effects and bacterial resistance 3
- Candida infections are uncommon in otherwise healthy prepubertal girls 2
- Consider anatomical factors that predispose young girls to vulvovaginitis 5
For Pregnant Women
- Avoid oral azoles in the first trimester 1
- Topical azoles are generally considered safe during pregnancy 1
For Immunocompromised Patients
- May require longer duration of therapy or higher doses 1
Practical Considerations
- Over-the-counter preparations (butoconazole, clotrimazole, miconazole, tioconazole) are appropriate for women with previously diagnosed VVC who have recurrence of the same symptoms 1
- Oil-based creams and suppositories may weaken latex condoms and diaphragms 1
- Patients should be instructed to return for follow-up only if symptoms persist or recur within 2 months 1
- Treatment of sexual partners is generally not recommended for VVC but may be considered for recurrent cases 1
Common Pitfalls to Avoid
- Treating Candida found on culture without symptoms (10-20% of women normally harbor Candida) 1
- Failing to identify non-albicans Candida species in recurrent cases, which may require different treatment approaches 1
- Inappropriate use of OTC preparations without proper diagnosis, which can delay treatment of other causes of vulvovaginitis 1
- Not considering other causes of vulvovaginitis such as bacterial infections, parasites, or foreign bodies in persistent cases 5, 4